Previous 10 | Next 10 |
Thomson Reuters ONE news releases related Thomson Reuters One news releases and Thomson Reuters One press releases from 05/07/20 07:00:10 on US and Canada...
LATHAM, N.Y., May 07, 2020 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ:PLUG), a leading provider of hydrogen engines and fueling solutions enabling e-mobility, has announced today its 2020 first quarter results. The quarterly shareholder letter has been posted at http://www.ir.plugpower.com/...
—Early intervention in hospitalized patients could help prevent progression of disease— —EDP1815 has demonstrated favorable tolerability and anti-inflammatory activity in a prior clinical trial— —Data expected during 2H 2020— —Evelo Mana...
Consolidated revenues of $3.7 billion, increasing by 5% year-over-year; consolidated adjusted EBIT (1) of $60 million, down 65% year-over-year, $156 million of reported EBIT; free cash flow usage (1) of $1.6 billion; operating cash flow usage of $1.5 billion Cash on hand of $2.1 billion...
May 7, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will convene an Extraordinary General Meeting of Shareholders (EGM) and publish the agenda with explanatory note shortly. The sole purpose of the EGM is submit to Philips’...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 06, 2020 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V / ASX: EMN) (the " Company " or " EMN ") is pleased to announce that, following the approval by 100% of...
VANCOUVER, British Columbia, May 06, 2020 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) is pleased to announce that it has published its 2019 Sustainability Report prepared under the Global Reporting Initiative Standards. The report highlights the Company’s sust...
Conference call and webcast on Thursday, May 7 at 2:30 pm CET/8:30 am ET TRYbeCA-1 Phase 3 Trial: More than 75% of the planned ~ 500 patients enrolled Fast-Drack designation granted by U.S. FDA Trial to continue as planned after third independent safety review Interim superi...
First patient treated in ongoing pivotal Phase 3 VIITAL™ study evaluating EB-101 for RDEB Additional patients dosed in the Phase 1/2 gene therapy studies for MPS IIIA and MPS IIIB Positive interim data from MPS III gene therapy programs presented at WORLDSymposium™...
Net cash used in operating and investing activities was $23.2 million in the first quarter; quarter-end cash and restricted cash position of $355.4 million provides funding to advance a broad pipeline DUBLIN, Ireland, May 06, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRT...
GAITHERSBURG, Md., May 06, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report its first quarter 2020 financial and operating results following the close of...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.98%Change Percent:
Axcelis Technologies Inc. Company Name:
ACLS Stock Symbol:
NASDAQ Market:
axcelis.com Website: